Abstract:Cancer is an important cause of death worldwide. The main types of cancer treatment are still surgery, chemotherapy and radiotherapy, and immunotherapy is becoming an important cancer treatment. Pyroptosis is a type of programmed cell death that accompanies an inflammatory response. This paper reviews the recent research progress in pyroptosis in tumors. Pyroptosis has been observed since 1986 and until recently has been recognized as programmed cell death mediated by GSDM family proteins. The molecular pathway of pyroptosis depends on the inflammasome-mediated caspase-1/GSDMD pathway, which is the canonical pathway, and the caspase-4/5/11/GSDMD pathway, which is the noncanonical pathway. Other pathways include caspase3/GSDME. Pyroptosis is a double-edged sword that is closely related to the tumor immune microenvironment. On the one hand, pyroptosis produces a chronic inflammatory environment, promotes the transition of normal cells to tumor cells, helps tumor cells achieve immune escape, and promotes tumor growth and metastasis. On the other hand, some tumor cell treatments can induce pyroptosis, which is a nonapoptotic form of cell death. Additionally, pyroptosis releases inflammatory molecules that promote lymphocyte recruitment and enhance the immune system's ability to kill tumor cells. With the advent of immunotherapy, pyroptosis has been shown to enhance the antitumor efficacy of immune checkpoint inhibitors. Some antineoplastic agents, such as chemotherapeutic agents, can also exert antineoplastic effects through the pyroptosis pathway. Pyroptosis, which is a programmed cell death mode, has been the focus of research in recent years, and the relationship between pyroptosis, tumors and tumor immunity has attracted attention, but there are still some questions to be answered regarding the specific mechanism. Further study of pyroptosis would aid in developing new antitumor therapies and has great clinical prospects.

Advancing Roles and Therapeutic Potentials of Pyroptosis in Host Immune Defenses against Tuberculosis

The Role of Pyroptosis in the Progression and Targeted Therapeutic Approaches for Urological Malignancies

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective

Pyroptosis in defense against intracellular bacteria

The role of pyroptosis in incomplete immune reconstitution among people living with HIV：Potential therapeutic targets

Research Progress of the Relationship Between Pyroptosis and Disease

Pyroptosis Provides New Strategies for the Treatment of Cancer

Insight to Pyroptosis in Viral Infectious Diseases

Ferroptosis: A new way to intervene in the game between Mycobacterium tuberculosis and macrophages

Pyroptosis in host defence against bacterial infection

Recent strategies for evoking immunogenic Pyroptosis in antitumor immunotherapy

Role of pyroptosis in the pathogenesis and treatment of diseases

Pyroptosis, a new bridge to tumor immunity

Applications of Pyroptosis Activators in Tumor Immunotherapy

Molecular mechanisms of pyroptosis and its role in anti-tumor immunity

Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target

Advances in research on the impact and mechanisms of pathogenic microorganism infections on pyroptosis

Pyroptosis As a Double-Edged Sword: the Pathogenic and Therapeutic Roles in Inflammatory Diseases and Cancers

Pyroptosis, metabolism, and tumor immune microenvironment

Mycobacterium tuberculosis PE_PGRS19 Induces Pyroptosis through a Non-Classical Caspase-11/GSDMD Pathway in Macrophages

Host Cell Death and Modulation of Immune Response against Mycobacterium tuberculosis Infection